Risk factors

CarMax faces heightened risks from activist shareholders, intense online competition, and internal restructuring impacts on workforce morale.

Substantial doubt exists regarding the company's ability to continue as a going concern due to liquidity and operating results challenges. FDA import alerts on key products like Ambrotose Life and Ambrotose Complex create operational disruptions. International markets represent 79.3% of net sales, heightening foreign currency and regulatory exposures.

Net losses increased to $5.9 million in 2025, bringing the accumulated deficit to $69.7 million.

Nocera adopted a Bitcoin treasury strategy, introducing volatility and regulatory risks. Operating losses increased to $2.67 million in 2025. Material weaknesses were identified in internal controls.

Nixxy transitioned from staffing to telecommunications and AI services, updating its risk profile for network costs and compliance.

Portfolio concentration shifted to fewer properties with 123 William Street driving 67% of straight-line rent.

The company adopted a Digital Asset Treasury Strategy allocating substantial liquidity to Worldcoin, Ethereum, OpenAI, and Beast Industries investments. Earnings and balance sheet values are now highly sensitive to crypto market volatility and ASU 2023-08 fair value accounting. Traditional packaging and inventory business risks were replaced by crypto custody, smart contract, and tax uncertainties.

Profusa completed its transition from a special purpose acquisition company to an operating medical device firm commercializing its Lumee Oxygen and Glucose Platform. The risk profile shifted entirely from business combination mechanics to clinical trial progress, Nasdaq listing compliance, going concern doubts, and heavy operational losses.

Polar Power effected a 1:7 reverse stock split to address Nasdaq minimum bid price deficiencies. Supplier concentration shifted, with Yanmar dropping to 70% and Ford engines through Engine Distributors rising to 18%.

The company completely shifted its strategy from pharmaceutical development to laser-based computing for blockchain and high-performance computing.

QVC Group faces Chapter 11 bankruptcy proceedings in the Southern District of Texas, threatening debt and equity values.

The company faces severe going-concern doubts with minimal cash and a heavy reliance on a credit line from an affiliate of Harry You. Nasdaq delisting warnings loom as market value and public float thresholds were breached. Artificial intelligence risks and internal control weaknesses are newly disclosed threats to operations.